Clinical Trial Update: Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating recruitment for neoadjuvant therapy with lenvatinib and pembrolizumab in renal cell carcinoma with inferior vena cava tumor thro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Renal Cell Carcinoma | Phase 2 | Status: RECRUITING